Pure Biologics SA

NEW
WAR:PUR (Poland)   Ordinary Shares
zł 2.15 -0.020 (-0.92%) Jul 10
At Loss
Market Cap:
zł 26.33M ($ 6.96M)
Enterprise V:
zł 41.75M ($ 11.04M)
Volume:
111.13K
Avg Vol (2M):
287.86K
Trade In:
Volume:
111.13K
At Loss

Business Description

Pure Biologics SA

ISIN : PLPRBLG00010

Share Class Description:

WAR:PUR: Ordinary Shares

Total Employee Number:

7
Description
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
Name Current Vs Industry Vs History
Cash-To-Debt
0.06
Equity-to-Asset
-10.32
Debt-to-Equity
-1
Debt-to-EBITDA
-2.54
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
36.3
3-Year EPS without NRI Growth Rate
31.2
3-Year FCF Growth Rate
33.8
Name Current Vs Industry Vs History
5-Day RSI
44.71
9-Day RSI
44.72
14-Day RSI
46.34
3-1 Month Momentum %
-14.29
6-1 Month Momentum %
-43.64
12-1 Month Momentum %
-36.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.09
Quick Ratio
0.09
Cash Ratio
0.06
Days Payable
25538.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-28.9
Shareholder Yield %
-21.6

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-444.29
ROIC %
-34.82
3-Year ROIIC %
-946.12
ROC (Joel Greenblatt) %
-4706.98
Name Current Vs Industry Vs History
EV-to-EBIT
-6.35
EV-to-EBITDA
-6.45
EV-to-FCF
-4.84
Earnings Yield (Greenblatt) %
-15.75
FCF Yield %
-32.79

Financials

WAR:PUR's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Pure Biologics SA Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł)
EPS (TTM) (zł) -1.597
Beta -0.2617
3-Year Sharpe Ratio 0.09
3-Year Sortino Ratio 0.24
Volatility % 130.4
14-Day RSI 46.34
14-Day ATR (zł) 0.188453
20-Day SMA (zł) 2.2765
12-1 Month Momentum % -36.06
52-Week Range (zł) 1.353 - 6.628356
Shares Outstanding (Mil) 12.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pure Biologics SA Filings

Filing Date Document Date Form
No Filing Data

Pure Biologics SA Stock Events

Financials Calendars
Event Date Price (zł)
No Event Data

Pure Biologics SA Frequently Asked Questions

What is Pure Biologics SA(WAR:PUR)'s stock price today?
The current price of WAR:PUR is zł2.15. The 52 week high of WAR:PUR is zł6.63 and 52 week low is zł1.35.
When is next earnings date of Pure Biologics SA(WAR:PUR)?
The next earnings date of Pure Biologics SA(WAR:PUR) is .
Does Pure Biologics SA(WAR:PUR) pay dividends? If so, how much?
Pure Biologics SA(WAR:PUR) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Pure Biologics SA

No articles.